Metabolic Syndrome Prevalence Study

Abdi Ibrahim Pharmaceuticals

Status

Completed

Conditions

Metabolic Syndrome

Treatments

Other: Metabolic Syndrome

Study type

Observational

Funder types

Industry

Identifiers

NCT02379702

METSAR-II

Details and patient eligibility

About

Following the first study conducted to investigate the prevalence of metabolic syndrome and its components in Turkey, it was aimed to demonstrate the change in general health condition of available patients after the period of time lapsed. This study will provide important information on the social and economic dimensions of metabolic syndrome and will contribute to development of preventive programs.

Full description

In the first METSAR-I study conducted in 2003, metabolic syndrome screening was made by two different team. Participants were visited at their addresses and informed about the research study and gave written consent. They were invited on an empty stomach for hospital visit on the day after. Pre-trained nurses completed the forms of patients during that second visit. After 11 years, a questionnaire by telephone survey will be applied to patients who participated in the METSAR-II study. The main goal is to determine the changes of metabolic syndrome population during that period.

Enrollment

1,659 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria